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Chondrogenic pharmacodynamics of rhGDF-5 dose and exposure 
duration
B.A. Byers1, D. Sundaresh2, S. Patel2, F. Binette2, J.J. Hwang2;
1Regenerative Therapeutics, Llc, Johnson & Johnson, Raynham, MA, 
United States of America, 2Sports Medicine, Johnson & Johnson 
Regenerative Therapeutics, LLC, Raynham, United States of 
America
Purpose: Growth and differentiation factor-5 (GDF-5) is a TGF-b 
superfamily signaling molecule that regulates chondrogenesis and 
limb development. In the current study, rhGDF-5 pharmacodynamic 
activity was evaluated using an in vitro chondrogenic assay to 
explore time-dependent enhancement of cartilage matrix synthesis 
and cell proliferation. Various growth factor doses and exposure 
durations were evaluated to establish a model system for predicting 
in vivo pharmacodynamics. 
Methods and Materials: Primary chondrocyte pellets were cultured 
JO B TFSVNGSFF DIFNJDBMMZEF¾OFE NFEJB TVQQMFNFOUFE XJUI
rhGDF-5 (1.4-1000 ng/ml) for 3, 7, 14, or 21d. Some cultures received 
transient rhGDF-5 exposure for only 3, 7, or 14d. Media was changed 
twice weekly. Matrix accumulation and cell proliferation were 
RVBOUJ¾FE UP JEFOUJGZ QFBL SFTQPOTF NJOJNBM FGGFDU EPTF 	.&%

and EC~50~. 
Results: Continuous rhGDF-5 supplementation demonstrated dose 
and time-dependent increases in sGAG content. Peak levels were 
achieved at 111 ng/ml, the MED decreased with culture duration 
(from 111 ng/ml (3d) to 4 ng/ml (21d), p<0.001), and the EC~50~ 
was 24 ng/ml at 21d. Increased cell proliferation (~2-fold) occurred 
at all time points but only at doses >37 ng/ml (p<0.001). Transient 
rhGDF-5 exposure for 14d provided equivalent dose-response 
characteristics at 21d as cultures treated continuously. Exposure for 
only 7d provided comparable peak sGAG accumulation at 1000 ng/ml 
(21d); however, the MED (37 ng/ml) and EC~50~ (210 ng/ml) were 
TJHOJ¾DBOUMZIJHIFS	Q<0.001) than those observed with continuous 
supplementation. 
Conclusions: These results provide new insight into rhGDF-
5 chondrogenic pharmacodynamics and establish a model for 
QSFEJDUJOH JO WJWP FG¾DBDZ PG DPNCJOBUPSJBM UIFSBQFVUJD TUSBUFHJFT
targeting growth factor dose and exposure duration. 
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Transplanted allogenic chondrocytes simultaneously 
overexpressing human insulin-like growth factor I (IGF-I) and 
¾CSPCMBTU HSPXUI GBDUPS 	'('
 TUJNVMBUF BSUJDVMBS DBSUJMBHF
repair in vivo
H. Madry1, G. Kaul1, P. Orth1, D. Zurakowski2, D. Kohn1,
M. Cucchiarini1;
1Dept. Of Orthopaedic Surgery, Saarland University, Labor für 
Experimentelle Orthopädie, Homburg, Germany, 2Children`s
Hospital, Harvard Medical School, Boston, United States of 
America
Purpose: 5SBOTQMBOUBUJPO PG HFOFUJDBMMZ NPEJ¾FE BSUJDVMBS
chondrocytes overexpressing either human IGF-I or FGF-2 enhances 
the repair of osteochondral defects in vivo. We tested the effect of 
articular chondrocytes transfected with a combination of IGF-I and 
FGF-2 on the repair of osteochondral defects in vivo. 
Methods and Materials: Chondrocytes were transfected with the E. 
coli lacZ gene or a combination of a human IGF-I and FGF-2 cDNA 
(IGF-I/FGF-2) using FuGENE 6, encapsulated in alginate and cultured 
for 21 days in vitro. IGF-I and FGF-2 concentrations were measured 
CZ &-*4" "MHJOBUFDIPOESPDZUF TQIFSFT XFSF QSFTT¾U JOUP
osteochondral defects (n=2) in each patellar groove of 14 rabbits. 
Three weeks post operation, cartilage repair was histologically 
graded based on 140 safranin-O-stained sections. Proteoglycan 
content of the repair tissue was measured using the DMMB assay. 
A mixed model analysis of variance was used to compare groups to 
account for multiple slides nested within the same animal. 
Results: *('*BOE'('FYQSFTTJPOMFWFMTXFSFTJHOJ¾DBOUMZIJHIFS
than in lacZ spheres until at least day 7. Combined gene transfer 
TJHOJ¾DBOUMZ JNQSPWFE ¾MMJOH PG UIF EFGFDU JOUFHSBUJPO NBUSJY
staining, cellular morphology, architecture of the defect and the 
surface and new subchondral bone formation. Average total score 
BGUFS  XFFLT JO WJWP XBT TJHOJ¾DBOUMZ JNQSPWFE GPS *('*'('
defects (15.97) compared with lacZ defects (21.91) (P < 0.001). 
Proteoglycan content of the repair tissue was 2.1-fold increased in 
IGF-I/FGF-2 defects (P = 0.02). 
Conclusions: The data demonstrate that the combined 
overexpression of IGF-I and FGF-2 within osteochondral defects 
TJHOJ¾DBOUMZFOIBODFTUIFSFQBJSBGUFSXFFLTJOWJWP
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Effect of TGF-ȕ1 and IGF-1 in an “in vitro” model of avascular 
meniscal lesions treated with different support materials
I. Izal Azcárate1, P. Ripalda Cemboráin1, C.A. Acosta Olivo2, F. Forriol 
Campos3;
1Orthopaedics Research Laboratory, University of Navarra, 
Pamplona, Spain, 2Cirugía Ortopedica Y Traumatología, Universidad 
Autónoma de Nuevo León, Monterrey, Mexico, 3Hospital Fremap, 
Hospital FREMAP, Madrid, Spain
Purpose: In vitro repair analysis of cylindrical lesions in the avascular 
zone of the meniscus by treating them with growth factors TGF-beta 
BOE*('BOE¾MMFEXJUIEJGGFSFOUTVQQPSUNBUFSJBMT
Methods and Materials: Avascular cylindric holes performed in the 
BWBTDVMBS [POFPG UIFNFOJTDVTXFSF¾MMFEXJUI DZMJOEFSTPG GSFTI
NFOJTDVTGSP[FONFOJTDBMBMMPHSBGUTBOEBSUJ¾DJBMDPMMBHFOTQPOHFT
cultivated with and without cartilage cells. All the groups were 
treated with TGF-beta1 and IGF-1 and analyzed after 2, 4, 6 and 8 
weeks 
Results: TGF-beta1 and IGF-1 induced the appearance of tissue 
VOJPOTCFUXFFOUIF¾MMJOHTUSVDUVSFBOEUIFFEHFTPGUIFMFTJPOBT
well as an increase in cell proliferation in meniscal cells. We also 
observed the presence of cells from the meniscus inside to the 
collagen sponges used, which was potentiated by the presence of 
TGF-beta1 and IGF-1. Cell presence in the sponge does not bear any 
correspondence with processes of proliferation. 
Conclusions: Filling the meniscal lesions with meniscal tissue or 
collagen matrices combined with TGF-beta1 and IGF-1 was useful to 
improve cell response processes in the experimental model used 
P180
A regenerative approach for osteochondral defects using delivered 
recombinant cartilage derived retinoic acid sensitive protein (CD-
RAP)
K. Hellerbrand1, S. Pippig2, C. Dony3;
1Pharmaceutical Technology, Scil Technology GmbH, Martinsried, 
Germany, 2Preclinical Development, Scil Technology GmbH, 
Martinsried, Germany, 3Cso, Scil Technology GmbH, Martinsried, 
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Purpose: Effective regeneration for traumatic cartilage damage 
PQUJPOTBSFOPUKFUBWBJMBCMF$%3"1JTBIJHIMZTQFDJ¾DNBSLFSGPS
cartilage and controls chondrogenic differentiation and maintenance. 
It was evaluated that CD-RAP improves cartilage healing in an animal 
model for critical size osteochondral defects. 
Methods and Materials: In 28 skeletally mature New Zealand White 
rabbits a critical size defect of 3 mm diameter and 3.5 mm depth 
were prepared in the middle of the trochlea. During the formation of 
the autologous blood clot 4 µg rhCD-RAP delivered within a collagen 
sponge were implanted. After an in life phase of 8 weeks the analysis 
was performed macroscopically and histologically by the Morris score. 
Results: The treatment with 4 µg rhCD-RAP immobilized on collagen 
TUBUJTUJDBMMZ TJHOJ¾DBOUMZ FOIBODF UIF GPSNBUJPO PG OFX DBSUJMBHF
compared to sham and vehicle control in the histological evaluation 
by the Morris score. The average scores for sham, vehicle control 
and treatments group with CD-RAP immobilized on collagen were 
16.5 ± 2.9, 16.2 ± 6.1, 8.1 ± 3.7. CD-RAP delivered on collagen showed 
BTJHOJ¾DBOUJNQSPWFNFOUPWFSUIFWFIJDMFBOETIBNHSPVQ
Conclusions: Results indicate that CD-RAP delivered on collagen in 
the defect site offers a new therapeutic approach for the regeneration 
of osteochondral defects. 
